Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2018

01-01-2018 | Editorial

Refining Risk for Deep Vein Thrombosis in Hospitalized Patients

Authors: Anna L. Parks, MD, R. Jeffrey Kohlwes, MD, MPH

Published in: Journal of General Internal Medicine | Issue 1/2018

Login to get access

Excerpt

Clinicians often assume that the test characteristics for a diagnostic test are fixed. This allows clinicians to smoothly transition from a pre-test to a post-test probability when considering diagnostic or treatment thresholds. Unfortunately, these “fixed” test characteristics apply best to the derivation group studied and may not always be generalizable to other populations. Applying a diagnostic test outside a derivation population may lead to “spectrum bias,” or the false assumption that a diagnostic test will work well in any population studied.1 An often-taught example of spectrum bias is the use of the outpatient-derived Wells score for the detection of deep venous thrombosis (DVT) in the inpatient setting. Compared to outpatients, hospitalized patients have a higher prevalence of pro-thrombotic characteristics such as immobility, comorbid illness and recent surgery, which makes the Wells score test characteristics less reliable in the inpatient setting. …
Literature
Metadata
Title
Refining Risk for Deep Vein Thrombosis in Hospitalized Patients
Authors
Anna L. Parks, MD
R. Jeffrey Kohlwes, MD, MPH
Publication date
01-01-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4194-8

Other articles of this Issue 1/2018

Journal of General Internal Medicine 1/2018 Go to the issue

Clinical Practice: Clinical Images

Checkpoint Inhibitor-Associated Hypophysitis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine